84 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
Call for Expressions of Interest: Small Molecule Screens for Beta Cell Regeneration and Survival
Expression of Interest Deadline: 12/18/2013
JDRF and the California Institute for Biomedical Research (Calibr) invite Expressions of Interest from investigators to participate in the JDRF-Calibr Translational Academic Research Partnership (TARP).
Researchers who have identified potential drug targets, pathways or screening approaches to promote beta cell regeneration and/or survival are encouraged to respond.
This program is designed to give investigators access to complete high-throughput small molecule screening capabilities and associated support, including assay development, hit identification and triaging, hit characterization, and structure-activity relationship studies.
Working closely with scientists at Calibr, investigators will identify and characterize novel modulators of targets, pathways, or cellular phenotypes relevant to islet biology and the restoration or preservation of beta cell mass and function in type 1 diabetes (T1D).
It is anticipated the newly discovered small molecule modulators will serve as research tool compounds to further dissect biological pathways, validate drug targets and provide starting points for more advanced medicinal chemistry/drug refinement.
Call for Applications: Interstitial Cystitis Association Pilot Research Grant
The Interstitial Cystitis Association (ICA) Pilot Research Grant is a one-year award of $25,000 intended to fund novel and useful basic, clinical, or translational research studies that attempt to solve the many questions of interstitial cystitis (IC). Specific areas of interest are (but not limited to):
Deadline to apply is February 28, 2014
Epidemiology/burden of disease (especially in children)
Etiology of IC
Serum or urine markers
Pregnancy and IC
Diet and nutrition
The deadline to apply is February 28, 2014. The award period is June 1, 2014 through May 31, 2015.
In order to be eligible for this award, the applicant must adhere to the following guidelines:
Applicant should have a sponsoring institution.
Applicant must be able to complete the proposed project within one year.
Applicant does not hold other research awards for the same or for a similar project.
If you have any further questions, please contact ICA at email@example.com.
CurePSP Grants Program
CurePSP has always believed that truly effective clinical interventions will follow good, solid basic scientific research. For this reason, CurePSP promotes research that helps generate an integrated picture of PSP and CBD at the molecular and cellular levels. CurePSP believes that in the long term, research of this nature will prove indispensable in developing a prevention or cure for PSP and CBD.
CurePSP has carefully structured its research program and has identified the programs that have been the most successful and those that need strengthening. With an increased research budget made possible through improved donor support, CurePSP will be able to markedly intensify the efforts to cure the disease in a way that promises relief for those afflicted today as well as hope for those who may be afflicted tomorrow.
Investigator-Initiated Research Projects
CurePSP accepts proposals for research projects by other investigators. CurePSP's Scientific Advisory Board reviews all submissions and recommends the most appropriate ones for funding. Details surrounding the submission of grants are as follows:
Grant application deadlines are quarterly on January 15, April 15, July 15, and October 15
Applicants will be notified when the grant is received by CurePSP
The Scientific Advisory Board will submit recommendations for funding at CurePSP's quarterly Board of Directors meeting
The maximum total grant amount awarded is $100,000. The period of the grant may be up to 3 years in duration but the total cannot exceed $100,000. However, greater or lesser amounts and durations may be offered depending on resources available
Any investigators interested in submitting a grant application should first review CurePSP's Research Policies and Procedures.
American Society of Transplantation Transplant Research Institute Grant Program
Since 1995, the American Society of Transplantation (AST) has invested millions of dollars to spur innovative research that has dramatically enhanced the field of organ transplantation. In an effort to benefit a broader number of investigators in more creative ways, the AST established the Transplant Research Institute (TRI) for the purposes of expanding the scope, reach, and effectiveness of the AST's research program. Among its many goals, the TRI seeks to elicit novel research topics and collaborative research opportunities from its partners in both industry and academia that are critical to advancing the science and practice of transplantation.
For 2014, the AST TRI considers applications in the following grant categories:
Faculty Development Grants
Basic Science Faculty Development Grant
Clinical Science Faculty Development Grant
Basic Science Fellowship Grant
Clinical Science Fellowship Grant
Applications for TRI grants must be completed by 11:59 PM Pacific Time on Monday, December 16, 2013. The submission site will automatically close after the deadline. No applications or supplementary documents will be accepted after the submission deadline.
The funding of any grant and total number of grants awarded by the TRI is dependent upon budgetary constraints in a given year. Grants may be funded for a one- or two-year period.
Letters of recommendation with original signatures on institutional letterhead must be uploaded to the online application.
Applicants for Faculty Development Grants and sponsors of Fellowship Grants must be members of the AST. If an applicant or sponsor is not a member, he/she must submit a completed membership application prior to the submission deadline. It is expected that membership will be active before the grant recipient is selected. 2014 AST membership dues must be paid by January 1, 2014. Apply for membership here.
Recipients of an AST TRI Grant will be recognized at the World Transplant Congress, July 26-31, 2014, in San Francisco. Recipients are expected to attend the WTC and must register for the congress. Registration to the WTC is NOT included with your grant.
No indirect costs are permitted.
Grant funding is not transferable from one recipient to another.
Research should begin on July 1, 2014.
DISCLAIMER: The AST will not assume responsibility for any clinical study funded by the TRI. Such proposals must be IRB-approved. Any responsibility will be assumed by the PI and the funded institution.
Cerebral Palsy International Research Foundation Research Grant Program
The Foundation provides funding for pilot studies on research important to the prevention, cure, and treatment of cerebral palsy, including improvement in the quality of life of persons with disabilities due to cerebral palsy. This broad research agenda includes basic, clinical and applied research in the biomedical and bioengineering sciences. Research grant applications are reviewed for scientific merit by independent referees, the Foundation’s Scientific Advisory Council, and finally, by the Foundation’s Board of Directors. Grants are awarded on a competitive basis taking into account scientific merit, scientific and clinical significance, and relevance to cerebral palsy. Grants are generally awarded for up to 2 years at a maximum of $50,000 a year.
The preparation and review of research grant applications requires a great deal of time and effort for all persons and organizations involved. In order to expedite the process, the following procedure is used for the submission of research grant proposals to the Cerebral Palsy International Research Foundation.
A mandatory “Letter of Intent” must be submitted (see address below) prior to the submission of a full application (due January 15, 2014). On the basis of the review of the letter, the investigator will be advised within two weeks whether the Foundation will accept a full application.
1. The letter should not exceed one typewritten page. It should briefly summarize:
Relevance of the project to cerebral palsy.
The research question being addressed and the research design of the proposal.
The potential impact of the results of the project on the biology of or clinical implications for cerebral palsy.
2. In addition to the one-page summary, the Letter of Intent should include a brief CV (NIH biosketch format) of the principal investigator.
3. For the 2014 research grant competition, the following exclusive priorities have been identified. No proposals will be considered that do not address one or more of these priorities:
Explore and test strategies for assessing, developing, and maintaining positive mental health among persons with cerebral palsy across the age spectrum. Of particular interest are projects focused on adolescents and adults (young, middle-aged, and elderly).
Compare and contrast one or more state’s (restricted to the U.S.) effective approach in implementing the Affordable Care Act (ACA) as it applies to individuals with cerebral palsy and other disabilities. Such a study should assist other states in improving health care while making the most effective use of limited resources. Consultation with UCP (United Cerebral Palsy) National Office or UCP local affiliates is recommended.
4. A complete Research Grant Application would be accepted following review and approval of the Letter of Intent. Once the Letter of Intent has been approved and notification of the approval received, a research grant application must be submitted by March 1, 2014. After merit review, the applicant will be advised if the proposal will be submitted to the Foundation’s Board of Directors for consideration for funding.
5. All research grant applications in the competitive scientific merit review priority range are presented to the Foundation’s Board of Directors for funding consideration (usually at its October meeting). Applicants are advised that the Board of Directors cannot guarantee funding for all of the projects in the priority range.
If you have any questions about the Foundation’s research grant program, please contact the Foundation at the following:
Cerebral Palsy International Research Foundation
186 Princeton Hightstown Road; Building 4; 2nd Floor
Princeton Junction, NJ 08550
American Society of Hematology Research Training Award for Fellows
Audience: Junior Investigator award for second and third-year fellows in the United States or Canada.
Award Amount: $55,000
Purpose: To allow fellows in training the benefit of protected time for research for one year
Audience: Senior Investigator award for fourth and fifth-year fellows in the United States or Canada
Award Amount: $55,000
Purpose: To allow fellows in training the benefit of protected time for research for one year
The ASH Research Training Award for Fellows (RTAF) is designed to encourage junior researchers in hematology, hematology/oncology, or other hematology-related training programs to pursue a career in academic hematology. The RTAF awards $55,000 to fellows in training so they will have protected time for research and is to be used primarily for salary support for the applicant. Awards are targeted to two separate groups of researchers: a Junior Investigator RTAF for second and third-year fellows (apply in years one or two of fellowship) and a Senior Investigator RTAF for fourth or fifth-year fellows (apply in years three or four of fellowship).
Up to six awards of $55,000 each will be given each year.
The goals of this program are to:
• Encourage and enable fellowship programs to provide time for research (clinical, basic science, or translational).
• Promote mentorship of hematology trainees by outstanding faculty members.
• Produce, on a yearly basis, clinician scientist candidates for academic positions.
• Provide bridging funds for trainees who need more time to generate sufficient expertise to be competitive when applying for K award funding.
The ASH Research Training Award for Fellows will grant $55,000 for a one-year period to two groups of fellows. The Junior Investigator RTAF is for second- and third-year fellows (at the time of the award), and the Senior Investigator RTAF is for fourth- or fifth-year fellows (at the time of the award) who are not yet eligible for the ASH Scholar Awards (fellow category) in the United States or Canada. Eligibility will begin on the first day of fellowship and go until five years from that date, with exceptions made for leaves of absence. Assistant professors are not eligible to apply.
The Research Training Award for Fellows is intended to be used primarily for salary support for the applicant. Salary includes benefits provided by applicant's institution for up to 15% of the total award amount. Additionally, up to $5,000 of the award money may be allocated for research supplies and reagents, and up to $1,000 may be allocated for travel to the ASH annual meeting (no other meetings are eligible for this allocation). Each of the non-salary support portions of the proposed budget must be accompanied by a clear justification.
Awards will be activated on July 1 and conclude on June 30 of the year following activation. Monies cannot be used toward salary/benefits for the mentor or toward an institution's overhead or indirect costs. Payments will be made to the appropriate financial officer of the institution.
All letter application submissions will be sent a confirmation email. If you do not receive a confirmation email, please contact the ASH Training Coordinator at firstname.lastname@example.org, or at 202-776-0544.
Applications due (received by 11:59 PM ET) January 15, 2014
Finalists interviews by study section in Washington, DC April 2014
Award notification May 2014
Award activation July 1, 2014
RTAF applicants are required to be members of ASH in good standing at the time of application, and for the duration of the RTAF program. If your 2014 dues have not been paid by 11:59 pm, Eastern, January 15, 2014, your application will be deemed ineligible. New Associate Membership applications should be submitted no later than December 1, 2013 to be processed.
To verify your membership status, please log on to the membership section of the ASH website. If you need assistance with your username and password, please contact an ASH Customer Relations Representative at email@example.com.
Applications for the 2014 award cycle must be received by 11:59 PM ET on January 15, 2014.
Junior Investigator Award
First and second-year fellows may apply to fund research in years two or three of fellowship. Eligible applicants must propose research focused on a hematologic condition (solid tumor projects are not eligible).
At the time of application, the applicant must:
• Possess an MD or DO. MD-PhDs, DO-PhDs and PhDs are not eligible unless the PhD is in a non biomedical field. National Institute of Health employees are not eligible for this award.
• Continue to maintain ASH membership and remain members in good standing of ASH for the duration of the RTAF award term.
• Be a first or second-year fellow in an ACGME or RCPSC accredited hematology, hematology/oncology, or hematology-related fellowship program in the United States or Canada. Eligibility will begin on the first day of fellowship and go until five years from that date, with exceptions made for leaves of absence. Assistant professors are not eligible to apply.
• Plan to pursue an investigative career in hematology research.
• Have a mentor who is an ASH member at the time the application is submitted and remain members of ASH for the duration of the RTAF award term. If the mentor is not in a hematology related field then a supporting letter from an ASH member is required. ( Additional mentors can be recommended by members of the study section)
• Have clear and documented support of an established mentor. This person should have funding (funding may be NIH, federal, foundation, or private) or be recognized through national clinical leadership (if the project is clinical). The mentor must remain funded during the award period.
• Provide documented support from the program director for dedicated research time during the award period.
• Secure a document from appropriate institutional leaders that states that at least 75 percent of the applicant's full-time professional efforts will be devoted to research during the funded period.
• Not hold a position as an Assistant Professor or Lecturer.
At the time of the award (July 1) the applicant must:
• Have completed one year of clinical training within a hematology, hematology/oncology, or hematology-related training program in the United States or Canada.
• Be a second or third-year fellow in an ACGME or RCPSC accredited hematology, hematology/oncology, or hematology-related training program in the United States or Canada.
• Continue to maintain ASH membership. Eligibility will begin on the first day of fellowship and go until five years from that date, with exceptions made for leaves of absence. Assistant professors are not eligible to apply.
• Not have any other career-development funding during the award period. Including but not limited to foundation and NIH career development, K12, K23, K01 K 8, T32), ASCO YIA, Leukemia and Lymphoma Society Clinical Scholar awards, etc.
• The RTAF is to be the recipient's main source of salary support. In the event that the recipient's salary is not fully covered by the Research Training Award for Fellows, supplementary funding from non career development awards or grants may be used to pay the balance of the recipient's salary.
• Not be accepted in the Clinical Research Training Institute or the Translational Research Training in Hematology programs during the research period of the awarded project.
• Not have accepted an ASH Scholar Award.
Criteria for selection include:
• A focus on hematology research.
• The qualifications and experiences of the applicant. Factors to be considered include, but are not limited to, the potential for future independent clinical or laboratory investigation and commitment to a career in hematology research.
• Quality of the mentor and the plan for mentor/applicant interaction and career development.
• The significance, feasibility, and originality of the proposed hypothesis, research, and methodology.
• Availability of institutional resources to support the proposed project.
Senior Investigator Award
Third and fourth-year fellows may apply to fund research in years four and five of fellowship. Eligible applicants must propose research focused on a hematologic condition (solid tumor projects are not eligible). Eligibility will begin on the first day of fellowship and go until five years from that date, with exceptions made for leaves of absence. Assistant professors are not eligible to apply.
• Continue to maintain ASH membership and remain members of ASH for the duration of the RTAF award term.
• Be in the third or fourth-year of a hematology, hematology/oncology, or hematology-related fellowship in the United States or Canada.
• Have clear and documented support of a funded mentor (funding may be NIH, federal, foundation, or private) or have a mentor recognized through national clinical leadership (if the project is clinical). The mentor must remain funded during the award period.
• Have a mentor who is an ASH member at the time the letter of intent is submitted, and remain members of ASH for the duration of the RTAF award term. If the research mentor is not in a hematology related field then a supporting letter from an ASH member is required. (Additional mentors can be recommended by members of the study section).
• Secure a document from appropriate institutional leaders that states that at least 75 percent of the applicant’s full-time professional efforts will be devoted to research during the funded period.
• Have completed two years of training within a hematology, hematology/oncology, or hematology-related training program in the United States or Canada.
• Be a fourth or fifth-year trainee in a hematology, hematology/oncology, or hematology-related training program in the United States or Canada. Eligibility will begin on the first day of fellowship and go until five years from that date, with exceptions made for leaves of absence. Assistant professors are not eligible to apply.
• Continue to maintain ASH membership.
• Not have any other career-development funding during the award period. Including but not limited to foundation and NIH career development (K12, K23, K01 K08, T32) ASCO YIA, Leukemia and Lymphoma Society Clinical Scholar awards, etc.
• The RTAF is to be the recipients' main source of salary support. In the event that the recipient's salary is not fully covered by the Research Training Award for Fellows, supplementary funding from non career development awards or grants may be used to pay the balance of the recipients' salary.
• The qualifications and experiences of the applicant. Factors to be considered include, but are not limited to the potential for future independent investigation and commitment to a career in hematology research.
Please Note: Any application which does not follow the stated requirements, includes additional documents outside of the required documents, is not formatted correctly, is lacking information, has incorrect information, or is lacking required documents as outlined in this document, will be deemed ineligible and will not be reviewed by the study section.
There are no appeals, or consideration for additional or further review once an application has been determined to be ineligible.
Questions regarding this application and the ASH Research Training Award for Fellows should be directed to the ASH Training Manager, at firstname.lastname@example.org or 202-776-0544.
Call for Applications: Cooley’s Anemia Foundation 2014-2015 Research Fellowships
The Cooley’s Anemia Foundation invites national and international applications for 2014-2015 Research Fellowships. Postdoctoral and junior faculty members investigating clinical or basic research related to thalassemia are eligible. Applications studying iron overload, iron chelation, methods of non-invasive iron measurement, quality of life, hepatitis C, osteoporosis, fertility, bone marrow transplantation and gene therapy are encouraged. Postdoctoral fellows should hold MD, PhD or equivalent degrees and require sponsorship by a faculty mentor. Junior faculty applicants should not have held the rank of Assistant Professor for more than 5 years and must not have already received R-01 level support. Stipends will be $32,500 annually with possibility of a one year renewal upon submission of a renewal application and approval by the Foundation’s Scientific Review Committee and Board of Directors. Successful postdoctoral fellows are expected to use the funds for salary support, whereas junior faculty applicants may use funds for salary or non-salary research support. Awards will be announced in June 2014.
The completed application is due Monday, February 3, 2014.
A scanned completed application in PDF format for each application is to be e-mailed to: email@example.com
For further information, please contact:
Cooley’s Anemia Foundation
330 Seventh Avenue #200
New York, NY 10001
800 522 7222